With increasing time since diagnosis, only the severe infections continued to cause symptoms.
The loss of activity is equivalent to 15% of the US population becoming completely immobile for 1 day.
Adult COVID-19 patients also infected with the flu are 4 times more likely to need mechanical ventilation and 2.4 times more likely to die.
The roadmap offers a powerful opportunity to leverage advances in vaccine science to better protect against influenza, including pandemic flu.
The Influenza Vaccines Roadmaps Initiative newsletter highlights recent news, research, and events pertaining to influenza vaccine R&D.
A database of novel vaccine candidates that are designed to provide broader and more durable protection against influenza viruses.
Help support our work on influenza. Advance the work of CIDRAP in public health preparedness and emerging infectious disease response.
Receive the latest infectious disease information.
(CIDRAP News) – The US Food and Drug Administration (FDA) yesterday approved a new diagnostic test developed by the Centers for Disease Control and Prevention (CDC) that can quickly distinguish seasonal influenza strains from an evolving virus that might have pandemic potential in hours rather than days.
(CIDRAP News) Public health officials in Hong Kong made headlines in March when they closed schools for 2 weeks to put a damper on an influenza epidemic, but a new report says the measure appears to have had little effect.
(CIDRAP News) Indonesian health minister Siti Fadilah Supari, who is at the center of an international controversy over sharing of H5N1 avian influenza virus samples, recently claimed that developed countries are creating new viruses as a means of building new markets for vaccines, according to an Agence France-Presse (AFP) report.
(CIDRAP News) Researchers who conducted genetic analyses of hundreds of influenza viruses collected during the 2006-07 flu season found that many different variants circulated in the US at the same time, suggesting that the way each year's epidemic spreads is more complicated than previously suspected.
(CIDRAP News) GlaxoSmithKline, maker of the antiviral drug zanamivir (Relenza), today launched a program designed to help businesses stockpile the drug as a strategy to protect employees in the event of an influenza pandemic.
Editor's Note: CIDRAP's Promising Practices: Pandemic Influenza Preparedness Tools (www.pandemicpractices.org) online database showcases peer-reviewed practices, including useful tools to help others with their planning. This article is one of a series exploring the development of these practices. We hope that describing the process and context of these practices enhances pandemic planning.
(CIDRAP News) Wildlife officials in Rhode Island recently announced that during routine surveillance they detected the low-pathogenic form of H7N3 avian influenza in wild mute swans.
The virus was detected in 4 of 11 swans collected from the Seekonk River, near the Swan Point Cemetery, about 4 miles northeast of Providence, according to an Aug 21 press release from the Rhode Island Department of Environmental Management (DEM).
(CIDRAP News) Two national nonprofit health groups are offering local public health departments a shot in the arm for fall influenza vaccination efforts by helping them organize immunization clinics at or near polling places.
(CIDRAP News) It was secondary bacterial pneumonianot the influenza virus by itselfthat killed most of the millions who perished in the 1918 flu pandemic, which suggests that current pandemic preparations should include stockpiling of antibiotics and bacterial vaccines, influenza researchers reported this week.
(CIDRAP News) A study of the blood of older people who survived the 1918 influenza pandemic reveals that antibodies to the strain have lasted a lifetime and can perhaps be engineered to protect future generations against similar strains.
